Peripheral Nerve Stimulation to Reduce Hypoxic Events
A Randomized Control Trial of the Oxistimulator as an Adjunct to Standard Practice to Decrease Extent and Duration of Oxygen Desaturation in Adult Patients Who Have Received Anesthetics or Are Receiving Sedating Medications
1 other identifier
interventional
80
1 country
1
Brief Summary
This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2015
CompletedFirst Posted
Study publicly available on registry
September 18, 2015
CompletedStudy Start
First participant enrolled
October 12, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 19, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 19, 2017
CompletedNovember 15, 2018
November 1, 2018
1.3 years
September 17, 2015
November 13, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Area Under the Curve for oxygen saturation (SpO2%)
One hour
Secondary Outcomes (3)
Frequency of desaturation episodes
One hour
Frequency of nursing interventions
One hour
Frequency of Adverse Events
72 hours
Study Arms (2)
Stimulator Active Device
EXPERIMENTALIntervention: This intervention arm will use a Stimulator Active Device peripheral nerve stimulation. Participants will receive a cutaneous stimuli in response to oxygen desaturations in postoperative surgical patients.
Stimulator Sham Device
SHAM COMPARATORNo intervention: This arm will use a Stimulator Sham Device peripheral nerve stimulation.Participants will not receive a cutaneous stimuli in response to oxygen desaturations in postoperative surgical patients.
Interventions
This is a stimulator active device that delivers peripheral nerve stimulation in conjunction with pulse oximetry information.
This is an stimulator sham device that is not providing peripheral nerve stimulation.
Eligibility Criteria
You may qualify if:
- Males and females \> 18 yrs old
- Flemon's Score \> 15
- Able to provide written informed consent
- Having gynecological, colorectal, orthopedic surgery, and urologic surgeries
- Baseline oxygen saturation on room air \> 96%
You may not qualify if:
- Peripheral neuropathy involving the upper extremities
- Procedures requiring direct admission to the ICU or any site other than the post-anesthesia care unit from the OR
- Diagnosed obstructive sleep apnea (OSA) and / or use of continuous positive airway pressure (CPAP) or biphasic positive airway pressure (BiPAP) in the PACU.
- Presence of any implantable electric devices, including internal defibrillators, pacemakers, or left ventricular assist device (LVAD)
- Post-procedure temperature \< 35.5 Celsius or evidence of vasoconstriction
- Presence of metal hardware in either arm or in either shoulder
- Patients lacking access to the bare skin on an arm after surgery.
- History of atrial fibrillation
- History of bundle branch block
- Females from menarche to menopause that do not have a current negative pregnancy test or surgical history preventing pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Related Publications (1)
Smith HM, Kilger J, Burkle CM, Schroeder DR, Gali B. Peripheral electrical stimulation reduces postoperative hypoxemia in patients at risk for obstructive sleep apnea: a randomized-controlled trial. Can J Anaesth. 2019 Nov;66(11):1296-1309. doi: 10.1007/s12630-019-01451-3. Epub 2019 Jul 23.
PMID: 31338807DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hugh Smith, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 17, 2015
First Posted
September 18, 2015
Study Start
October 12, 2015
Primary Completion
January 19, 2017
Study Completion
January 19, 2017
Last Updated
November 15, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share